Despite its potential, nanotherapy faces several challenges:
Toxicity: The long-term effects and potential toxicity of nanoparticles are still not fully understood, requiring extensive research and evaluation. Production Costs: The manufacturing of nanoparticles can be expensive and complex, which may limit their widespread adoption. Regulatory Hurdles: The approval process for nanotherapeutic agents is rigorous and can be time-consuming, posing significant regulatory challenges. Delivery Efficiency: Ensuring that nanoparticles reach their intended target and release their payload effectively remains a significant challenge.
